Streetbeat News

Stock Prices

AVDE

AVSD

UBS

UBS Group AG announced that AT1 bonds worth ~$5 billion are now available for equity conversion, following a shareholder decision. This covers four AT1 issuances since November 2023. UBS reported Q1 FY24 sales of $12.74 billion and EPS of $0.52, surpassing consensus estimates. The bank also anticipates completing the merger with Credit Suisse AG by May 31. UBS stock has gained over 54% in the past year, and investors can gain exposure through AVDE and AVSD ETFs.

Portfolio Pulse from Lekha Gupta

May 13, 2024 | 2:05 pm

KBH

Zelman & Assoc analyst Ivy Zelman downgraded KB Home (NYSE:KBH) from Neutral to Underperform and set a $69 price target. This reflects a negative outlook on the company's stock performance.

Portfolio Pulse from Benzinga Newsdesk

May 13, 2024 | 2:02 pm

ALGM

Analysts have mixed views on Allegro Microsystems (NASDAQ:ALGM), with ratings ranging from bullish to bearish. The average 12-month price target is now $34.17, down from $38.75, indicating a negative sentiment shift. Recent actions include price target adjustments and new ratings, reflecting analysts' responses to market conditions and company performance. Allegro Microsystems, a key player in sensor ICs and analog power ICs for automotive and industrial markets, faces revenue challenges and a decline in market capitalization, yet shows efficient cost management.

Portfolio Pulse from Benzinga Insights

May 13, 2024 | 2:01 pm

GRTS

Gritstone Bio (NASDAQ:GRTS) received mixed analyst ratings, with a recent shift towards more bullish perspectives. The average 12-month price target is now $5.00, down 9.09% from the previous target. Financial challenges include a significant revenue decline and poor profitability metrics. Analysts' actions and price target adjustments reflect dynamic market conditions and company performance.

Portfolio Pulse from Benzinga Insights

May 13, 2024 | 2:01 pm

GME

GameStop shares experienced a significant surge, leading to multiple trading halts due to circuit breakers being triggered. The stock is now up by 110.2%.

Portfolio Pulse from Benzinga Newsdesk

May 13, 2024 | 2:00 pm

DNOW

Analysts have mixed views on DNOW, with recent evaluations showing a shift towards a more neutral stance. The average 12-month price target is $15.6, indicating an 11.43% increase from the previous target. DNOW's financial performance is strong, with notable revenue growth, high net margin, and effective asset utilization.

Portfolio Pulse from Benzinga Insights

May 13, 2024 | 2:00 pm

HLT

Over the past decade, Hilton Worldwide Holdings (NYSE:HLT) has delivered an average annual return of 16.49%, outperforming the market by 5.72%. A $100 investment in HLT 10 years ago would now be worth $449.47. The company's current market capitalization stands at $52.06 billion.

Portfolio Pulse from Benzinga Insights

May 13, 2024 | 2:00 pm

ICLR

Over the past 20 years, Icon (NASDAQ:ICLR) has delivered an average annual return of 19.08%, outperforming the market by 10.97% on an annualized basis. With a current market capitalization of $25.89 billion, a $100 investment in ICLR 20 years ago would be worth $3,293.72 today.

Portfolio Pulse from Benzinga Insights

May 13, 2024 | 2:00 pm

MCHP

Microchip Technology (NASDAQ:MCHP) has received 17 analyst ratings in the past three months, showing a mix of bullish to bearish sentiments. The average 12-month price target is $99.76, reflecting an 8.12% increase from the previous target of $92.27. Analysts from firms like Jefferies, Citigroup, and Goldman Sachs have raised their price targets, indicating a positive outlook on MCHP's performance. Despite this, the company faces challenges with a -24.91% revenue decline and below-average ROE and ROA, suggesting potential financial hurdles.

Portfolio Pulse from Benzinga Insights

May 13, 2024 | 2:00 pm

SRG

Seritage Growth Properties is in negotiations to sell four assets for $79.1 million, causing its shares to trade higher.

Portfolio Pulse from Benzinga Newsdesk

May 13, 2024 | 1:59 pm